BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30382482)

  • 1. Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade.
    Chobrutskiy BI; Zaman S; Tong WL; Diviney A; Blanck G
    J Neurooncol; 2018 Dec; 140(3):697-704. PubMed ID: 30382482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of immune receptor recombination databases sourced from tumour exome or RNAseq files: Verifications of immunological distinctions between primary and metastatic melanoma.
    Patel DN; Yeagley M; Arturo JF; Falasiri S; Chobrutskiy BI; Gozlan EC; Blanck G
    Int J Immunogenet; 2021 Oct; 48(5):409-418. PubMed ID: 34298587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune receptor recombinations from breast cancer exome files, independently and in combination with specific HLA alleles, correlate with better survival rates.
    Tong WL; Callahan BM; Tu YN; Zaman S; Chobrutskiy BI; Blanck G
    Breast Cancer Res Treat; 2019 Jan; 173(1):167-177. PubMed ID: 30229447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRB-J1 usage, in combination with the HLA-A*01:01 allele, represents an apparent survival advantage for uterine corpus endometrial carcinoma: Comparisons with microscopic assessments of lymphocyte infiltrates.
    Clark KR; Tong WL; Callahan BM; Yavorski JM; Tu YN; Blanck G
    Int J Immunogenet; 2019 Feb; 46(1):31-37. PubMed ID: 30474304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing microenvironment immunogenicity using tumor specimen exomes: Co-detection of TcR-α/β V(D)J recombinations correlates with PD-1 expression.
    Tu YN; Tong WL; Samy MD; Yavorski JM; Kim M; Blanck G
    Int J Cancer; 2017 Jun; 140(11):2568-2576. PubMed ID: 28256716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRBV and TRBJ usage, when paired with specific HLA alleles, associates with distinct head and neck cancer survival rates.
    Arndt MF; Koohestani DM; Chobrutskiy BI; Mihyu MM; Diaz M; Gozlan EC; Yeagley M; Zaman S; Roca AM; Blanck G
    Hum Immunol; 2020 Dec; 81(12):692-696. PubMed ID: 32950267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell Receptor Recombinations in Lung Adenocarcinoma Exome Files Correlate With a Higher Overall Survival Rate.
    Tu YN; Tong WL; Callahan BM; Chobrutskiy BI; Blanck G
    Anticancer Res; 2020 Apr; 40(4):2043-2051. PubMed ID: 32234895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
    Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
    Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung tumor exome files with T-cell receptor recombinations: a mouse model of T-cell infiltrates reflecting mutation burdens.
    Tu YN; Tong WL; Fawcett TJ; Blanck G
    Lab Invest; 2017 Dec; 97(12):1516-1520. PubMed ID: 28805806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of immunoglobulin V(D)J recombinations in solid tumor specimen exome files: Evidence for high level B-cell infiltrates in breast cancer.
    Tong WL; Tu YN; Samy MD; Sexton WJ; Blanck G
    Hum Vaccin Immunother; 2017 Mar; 13(3):501-506. PubMed ID: 28085544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on the Prognostic Values of Dynactin Genes in Low-Grade Glioma.
    Su X; Li H; Chen S; Qin C
    Technol Cancer Res Treat; 2021; 20():15330338211010143. PubMed ID: 33896271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell receptor gene recombinations in human tumor specimen exome files: detection of T cell receptor-β VDJ recombinations associates with a favorable oncologic outcome for bladder cancer.
    Samy MD; Tong WL; Yavorski JM; Sexton WJ; Blanck G
    Cancer Immunol Immunother; 2017 Mar; 66(3):403-410. PubMed ID: 27995306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploiting adaptive immune receptor recombination read recoveries from exome files to identify subsets of ALL and to establish TCR features that correlate with better outcomes.
    Gozlan EC; Chobrutskiy BI; Blanck G
    Int J Lab Hematol; 2022 Oct; 44(5):883-891. PubMed ID: 35527672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell receptor V and J usage paired with specific HLA alleles associates with distinct cervical cancer survival rates.
    Roca AM; Chobrutskiy BI; Callahan BM; Blanck G
    Hum Immunol; 2019 Apr; 80(4):237-242. PubMed ID: 30684568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TcR-α recombinations in renal cell carcinoma exome files correlate with an intermediate level of T-cell exhaustion biomarkers.
    Mai AT; Tong WL; Tu YN; Blanck G
    Int Immunol; 2018 Feb; 30(1):35-40. PubMed ID: 29361059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of Immunoglobulin VJ Recombinations from Pancreatic Cancer Exome Files Strongly Correlates with Reduced Survival.
    Kinskey JC; Tu YN; Tong WL; Yavorski JM; Blanck G
    Cancer Microenviron; 2018 Jun; 11(1):51-59. PubMed ID: 29404962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral T Cell Receptor Complementarity Determining Region-3 Sequences Are Associated with a Worse Cancer Outcome: A Pancancer Analysis.
    Zaman S; Chobrutskiy BI; Patel JS; Diviney A; Tu YN; Tong WL; Gill T; Blanck G
    Viral Immunol; 2020 Jun; 33(5):404-412. PubMed ID: 32315578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grade II/III Glioma Microenvironment Mining and Its Prognostic Merit.
    Chen J; Hou C; Wang P; Yang Y; Zhou D
    World Neurosurg; 2019 Dec; 132():e76-e88. PubMed ID: 31518750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NFE2L2 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltration in Brain Lower Grade Glioma: A Pan-Cancer Analysis.
    Ju Q; Li X; Zhang H; Yan S; Li Y; Zhao Y
    Oxid Med Cell Longev; 2020; 2020():3580719. PubMed ID: 33101586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenomics of colorectal adenocarcinoma: Survival distinctions represented by immune receptor, CDR3 chemical features and high expression of BTN gene family members.
    Diaz MJ; Chobrutskiy BI; Zaman S; Blanck G
    Cancer Treat Res Commun; 2020; 24():100196. PubMed ID: 32769037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.